Publications
- Humoral and cellular immune responses to mRNA COVID-19 vaccines in patients with axial spondyloarthritis treated with adalimumab or secukinumab2022 | Second Faculty of Medicine
- Genomics Driving Diagnosis and Treatment of Inborn Errors of Immunity with Cancer Predisposition2022 | Second Faculty of Medicine
- Natural Course of Activated Phosphoinositide 3-Kinase Delta Syndrome in Childhood and Adolescence2021 | Second Faculty of Medicine, First Faculty of Medicine
- An immunologist's perspective on anti-COVID-19 vaccines2021 | Second Faculty of Medicine
- Hyper-IgE in the allergy clinic-when is it primary immunodeficiency?2018 | Second Faculty of Medicine
- Clinical outcomes, immunogenicity, and safety of BNT162b22 Vaccine in Primary Antibody Deficiency2023 | Second Faculty of Medicine
- Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies2023 | Second Faculty of Medicine
- Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds?2023 | Second Faculty of Medicine
- Gastrointestinal Involvement in Primary Antibody Deficiencies2023 | Second Faculty of Medicine
- Activated Phosphoinositide 3-Kinase δ Syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity2023 | Second Faculty of Medicine
Loading network view...
